Recursion Pharmaceuticals, Inc. (RXRX) Ownership

$4.92

$0.26 (5.58%)
Last update: 04:00 PM EST
Day's range
$4.58
Day's range
$4.94

Recursion Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 11/07/2025 39.78 M $194.13 M   10.28% 9.53%
ARK INVESTMENT MANAGEMENT LLC 11/12/2025 33.55 M $163.70 M   1.69% 8.04%
BLACKROCK, INC. 11/12/2025 31.74 M $154.89 M   11.87% 7.60%
BAILLIE GIFFORD & CO 10/31/2025 23.98 M $117.02 M   -0.81% 5.75%
STATE STREET CORP 11/14/2025 18.27 M $89.15 M   63.41% 4.38%
SOFTBANK GROUP CORP. 11/14/2025 14.67 M $71.58 M   0.00% 3.51%
KINNEVIK AB (PUBL) 11/04/2025 13.43 M $65.56 M   0.00% 3.22%
MUBADALA INVESTMENT CO PJSC 11/14/2025 12.99 M $63.37 M   0.00% 3.11%
MIC CAPITAL MANAGEMENT UK LLP 11/14/2025 9.64 M $47.06 M   0.00% 2.31%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 9.62 M $46.97 M   23.75% 2.31%
NOVO HOLDINGS A/S 11/14/2025 7.93 M $38.70 M   -17.95% 1.90%
NVIDIA CORP 11/14/2025 7.71 M $37.61 M   0.00% 1.85%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 10/27/2025 7.47 M $36.43 M   -8.59% 1.79%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 11/12/2025 7.47 M $36.36 M   -8.59% 1.79%
MORGAN STANLEY 11/14/2025 7.29 M $35.58 M   28.13% 1.75%
DATA COLLECTIVE IV GP, LLC 11/14/2025 5.94 M $28.99 M   0.00% 1.42%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 5.39 M $26.30 M   68.13% 1.29%
UBS ASSET MANAGEMENT AMERICAS INC 11/14/2025 4.20 M $20.48 M   -9.07% 1.01%
DCVC OPPORTUNITY FUND II GP, LLC 11/14/2025 3.95 M $19.28 M   0.00% 0.95%
UBS GROUP AG 11/13/2025 3.75 M $18.32 M   -18.94% 0.90%
EXOR CAPITAL LLP 11/13/2025 3.68 M $17.93 M   0.00% 0.88%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 3.45 M $16.81 M   33.05% 0.83%
NORTHERN TRUST CORP 11/14/2025 3.34 M $16.29 M   14.49% 0.80%
FMR LLC 11/13/2025 3.23 M $15.76 M   -42.19% 0.77%
TWO SIGMA INVESTMENTS, LP 11/14/2025 2.45 M $11.96 M   109.86% 0.59%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 2.16 M $10.55 M   30.00% 0.52%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 2.03 M $9.93 M   -14.16% 0.49%
CITADEL ADVISORS LLC 11/14/2025 1.94 M $9.48 M   13.26% 0.47%
FIRST TRUST ADVISORS LP 11/12/2025 1.80 M $8.77 M   -4.42% 0.43%
IQ EQ FUND MANAGEMENT (IRELAND) LTD 11/05/2025 1.77 M $8.66 M   94.82% 0.43%
PICTET & CIE (EUROPE) SA 10/21/2025 1.63 M $7.95 M   100.00% 0.39%
BARCLAYS PLC 11/12/2025 1.55 M $7.57 M   33.10% 0.37%
BANK OF NEW YORK MELLON CORP 11/03/2025 1.37 M $6.68 M   26.68% 0.33%
CITADEL ADVISORS LLC 11/14/2025 1.35 M $6.58 M   2.60% 0.32%
NUVEEN, LLC 11/12/2025 1.28 M $6.23 M   4.14% 0.31%
GOLDMAN SACHS GROUP INC 11/14/2025 1.26 M $6.16 M   11.53% 0.30%
PEAK6 LLC 11/14/2025 1.24 M $6.03 M   -14.69% 0.30%
BANK OF AMERICA CORP /DE/ 11/14/2025 1.22 M $5.97 M   -11.24% 0.29%
CITADEL ADVISORS LLC 11/14/2025 1.09 M $5.32 M   55.98% 0.26%
COMPREHENSIVE FINANCIAL MANAGEMENT LLC 11/14/2025 941.90 K $4.60 M   0.00% 0.23%
TWO SIGMA ADVISERS, LP 11/14/2025 815.45 K $3.98 M   100.00% 0.20%
WELLS FARGO & COMPANY/MN 11/13/2025 801.37 K $3.91 M   269.24% 0.19%
RAFFERTY ASSET MANAGEMENT, LLC 11/12/2025 750.19 K $3.66 M   110.63% 0.18%
CAPITAL FUND MANAGEMENT S.A. 11/13/2025 726.02 K $3.54 M   0.76% 0.17%
JANE STREET GROUP, LLC 11/14/2025 721.55 K $3.52 M   100.00% 0.17%
LIONTRUST INVESTMENT PARTNERS LLP 11/24/2025 702.39 K $3.55 M   0.00% 0.17%
DIADEMA PARTNERS LP 11/14/2025 698.40 K $3.41 M   0.00% 0.17%
VESTMARK ADVISORY SOLUTIONS, INC. 11/10/2025 621.06 K $3.03 M   -53.62% 0.15%
SWISS NATIONAL BANK 11/13/2025 620.60 K $3.03 M   9.61% 0.15%
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC 11/13/2025 595.52 K $2.91 M   0.00% 0.14%

Recursion Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 401 institutional investors and hedge funds held shares of Recursion Pharmaceuticals, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 39.78 M

ARK Investment Management LLC: 33.55 M

BlackRock, Inc.: 31.74 M

BAILLIE GIFFORD & CO: 23.98 M

STATE STREET CORP: 18.27 M

SOFTBANK GROUP CORP.: 14.67 M

77.82% of Recursion Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 355.88 M shares in the last 24 months. This purchase volume represents approximately $1.75 B in transactions.